Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 324
Selected: 0
NCT IDTitle
NCT04746287Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
NCT07577518Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome
NCT03063697Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
NCT01352689CKD-828(80/2.5mg) Pharmacokinetic Study_2nd
NCT01663038Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination
NCT05816759Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150
NCT05634447A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391
NCT01685671Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers
NCT04223895A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
NCT02358824CKD-828 (80/5mg) Pharmacokinetic Study
NCT06838286Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
NCT02247505CKD-397 Drug-drug Interaction Study (B)
NCT01684605Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers
NCT03609606A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
NCT05587699The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
NCT05928637A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
NCT02526875Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
NCT05897216Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029
NCT06709807Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
NCT07365358Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
NCT01560325Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT01842256Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
NCT01819870Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
NCT03210649Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02002611Drug-drug Interaction Study(Lobeglitazone, Warfarin)
NCT02480465Efficacy and Safety of Lobeglitazone Versus Sitagliptin
NCT04246190A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
NCT01630018Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
NCT04667975The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
NCT03868072Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers
NCT01369472Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule
NCT04867720Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients
NCT02288338CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
NCT02586311CKD-330 Phase 3 Trial in Amlodipine Non-responder
NCT04555434Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH
NCT04676893Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
NCT03382756A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337
NCT04830930A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers
NCT01580371Safety and Pharmacokinetic Profile of CKD-581
NCT02685774A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers
NCT05108038A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04906785Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT01340248A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers
NCT02805738Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet
NCT03646799Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults
NCT04478097Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
NCT02206165A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
NCT04312698Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
NCT02451098Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
NCT04673695A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344